Measurement of spleen volume is useful for distinguishing between simple steatosis and early-stage non-alcoholic steatohepatitis

Hepatology Research

Volumn 40, Issue 7, 2010, Pages 693-700

  Suzuki, Kaori ^a   Kirikoshi, Hiroyuki ^a   Yoneda, Masato ^a   Mawatari, Hironori ^a   Fujita, Koji ^a   Nozaki, Yuichi ^a   Takahashi, Hirokazu ^a   Abe, Yasunobu ^a   Inamori, Masahiko ^a   Shimamura, Takeshi ^a   Kobayashi, Noritoshi ^a   Kubota, Kensuke ^a   Saito, Satoru ^a   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Liver fibrosis; Non alcoholic steatohepatitis; Spleen volume

Indexed keywords

ADULT; ARTICLE; BODY SURFACE; COMPUTED TOMOGRAPHY SCANNER; FEMALE; FIBROSIS; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; STEATOSIS;

EID: 77954747171     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00643.x     Document Type: Article

References (34)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-31.
2. Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003, 18:124-38.
3. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980, 55:434-8.
4. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001, 21:3-16.
5. Cadranel JF. [Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future]. Gastroenterol Clin Biol 2002, 26:823-4.
6. Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000, 14:543-8.
7. Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007, 46:582-9.
8. Yoneda M, Mawatari H, Fujita K. Type IV collagen 7 s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. J Gastroenterol 2007, 42:375-81.
9. Yoneda M, Mawatari H, Fujita K. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol 2007, 42:573-82.
10. Yoneda M, Uchiyama T, Kato S. Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH). BMC Gastroenterol 2008, 8:53.
11. Yoneda M, Mawatari H, Fujita K. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008, 40:371-8.
12. Nakamura S, Konishi H, Kishino M. Prevalence of esophagogastric varices in patients with non-alcoholic steatohepatitis. Hepatol Res 2008, 38:572-9.
13. Bolognesi M, Merkel C, Sacerdoti D, Nava V, Gatta A. Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis 2002, 34:144-50.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-9.
15. Yoshizumi T, Nakamura T, Yamane M. Abdominal fat: standardized technique for measurement at CT. Radiology 1999, 211:283-6.
16. Kleiner DE, Brunt EM, Van Natta M. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-21.
17. Hiroshige S, Shimada M, Harada N. Accurate preoperative estimation of liver-graft volumetry using three-dimensional computed tomography. Transplantation 2003, 75:1561-4.
18. Fujimoto S, Watanabe T, Sakamoto A, Yukawa K, Morimoto K. [Studies on the physical surface area of Japanese. 18. Calculation formulas in three stages over all ages]. Nippon Eiseigaku Zasshi 1968, 23:443-50.
19. Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology 2007, 133:1814-20.
20. Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol 2004, 2:1048-58.
21. DeLand FH. Normal spleen size. Radiology 1970, 97:589-92.
22. McCormick WF, Kashgarian M. The weight of the adult human spleen. Am J Clin Pathol 1965, 43:332-3.
23. Prassopoulos P, Daskalogiannaki M, Raissaki M, Hatjidakis A, Gourtsoyiannis N. Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol 1997, 7:246-8.
24. Reynolds TB, Hidemura R, Michel H, Peters R. Portal hypertension without cirrhosis in alcoholic liver disease. Ann Intern Med 1969, 70:497-506.
25. Nakano M, Worner TM, Lieber CS. Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. Gastroenterology 1982, 83:777-85.
26. Miyakawa H, Iida S, Leo MA, Greenstein RJ, Zimmon DS, Lieber CS. Pathogenesis of precirrhotic portal hypertension in alcohol-fed baboons. Gastroenterology 1985, 88:143-50.
27. Orrego H, Blendis LM, Crossley IR. Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat. Gastroenterology 1981, 80:546-56.
28. Israel Y, Britton RS, Orrego H. Liver cell enlargement induced by chronic alcohol consumption: studies on its causes and consequences. Clin Biochem 1982, 15:189-92.
29. Blendis LM, Orrego H, Crossley IR, Blake JE, Medline A, Isreal Y. The role of hepatocyte enlargement in hepatic pressure in cirrhotic and noncirrhotic alcoholic liver disease. Hepatology 1982, 2:539-46.
30. Israel Y, Orrego H, Colman JC, Britton RS. Alcohol-induced hepatomegaly: pathogenesis and role in the production of portal hypertension. Fed Proc 1982, 41:2472-7.
31. Colman JC, Britton RS, Orrego H, Saldivia V, Medline A, Israel Y. Relation between osmotically induced hepatocyte enlargement and portal hypertension. Am J Physiol 1983, 245:G382-387.
32. Tsushima Y, Endo K. Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen. Dig Dis Sci 2000, 45:196-200.
33. Tarantino G, Conca P, Pasanisi F. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 2009, 21:504-11.
34. Saadeh S, Younossi ZM, Remer EM. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123:745-50.